Akebia Therapeutics Forges Deals To Manage Costs And Profitability – Seeking Alpha


Seeking Alpha

Akebia Therapeutics Forges Deals To Manage Costs And Profitability
Seeking Alpha
While the distribution deal is contingent upon the approval of the system by the US Food and Drug Administration, it also provided for Vifor injecting $50 million equity funds into Akebia. The deal valued Akebia Therapeutics stock at $14 apiece

and more »

Read More…

Share This: